Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.11B | $1.20B | $1.25B | $1.21B | $1.48B | $1.44B | $1.57B | $1.63B |
| Cost of revenue | $927.4M | $950.1M | $1.09B | $1.09B | $1.30B | $1.28B | $1.28B | $1.30B |
| Gross profit | $182.7M | $245.8M | $158.2M | $124.9M | $176.0M | $161.9M | $286.2M | $324.6M |
| Gross margin | 16.5% | 20.6% | 12.7% | 10.3% | 11.9% | 11.2% | 18.2% | 19.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$74.8M | $16.5M | −$1.4M | −$12.9M | −$21.1M | −$39.3M | $83.2M | $86.1M |
| EBITDA | $31.3M | $36.4M | $70.8M | $69.8M | $52.3M | $46.5M | $174.8M | $183.4M |
| Net income | −$61.1M | $34.9M | $17.5M | −$111.9M | −$137.3M | −$123.6M | $11.3M | $28.8M |
| Net margin | -5.5% | 2.9% | 1.4% | -9.2% | -9.3% | -8.6% | 0.7% | 1.8% |
| EPS (diluted) | 325114422.00 | 0.05 | -25740795.00 | -0.15 | -0.19 | -0.17 | 0.01 | 0.03 |
Annual figures · source: Financial Modeling Prep
CHINA MEDICAL &HEALTH LTD
No one on the platform currently holds COLRF.
No tracked institution reports a position in COLRF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-05-27 | $0.0200 | 2025-06-27 |
| Execution date | Ratio |
|---|---|
| 2023-02-24 | 1-for-20reverse |
| 2015-06-16 | 20-for-1 |
| 2008-06-19 | 6-for-5 |
No one on the platform has traded COLRF yet.
| — |
| $109M |
| — |
| COPHFCreso Pharma Limited | $0.12 | +0.00% | $132M | — |
| CSAMFCSAM Health Group AS | $4.82 | +0.00% | $99M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.